https://www.selleckchem.com/pr....oducts/ITF2357(Givin
djunct to ultrasound in the diagnosis of placenta accreta spectrum. Pregnant women with moderate symptoms of COVID-19 are at risk for progressing to severe or critical illness. While there are limited data on the management of severe COVID-19 during pregnancy, information on pharmacological treatments of moderate COVID-19 is lacking. We report clinical outcomes of pregnant women hospitalized due to moderate COVID-19 illness treated with a 5-day course of remdesivir, antibiotics, and/or glucocorticoids. Case series of pregnan
Curtir
Comentario
Compartilhar
